# MSD Animal Health

Sequivity RNA particles — Custom RNA replicon vaccines.

Source: https://cn.bioecon.ru/companies/msd-animal-health/
Updated: 2026-06-25

- 国家: Netherlands

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 营收 | $56亿（2023年） | https://www.msd-animal-health.com/downloads/msd-animal-health-corporate-fact-sheet/ |
| 产能 | 全部产能合计年产55 billion剂，其中一家工厂日产疫苗150 million剂 | https://brabantbusinessregion.com/msd-animal-health-opens-new-state-of-the-art-vaccine-factory-in-brabant/, https://investinholland.com/news/msd-animal-health-advanced-vaccine-production-facility-netherlands/, https://msd.nl/boxmeer/ |
| 生产基地 | Boxmeer，荷兰 | https://investinholland.com/news/msd-animal-health-advanced-vaccine-production-facility-netherlands/, https://msd.nl/boxmeer/, https://www.msd-animal-health.nl/wp-content/uploads/sites/14/2020/02/Bedrijfsbrochure_MSD_AH_-_nederlands_-_final_tcm100-186622.pdf |
| 员工人数 | MSD Animal Health Nederland约800-900名员工（Boxmeer基地报告约2,000名员工） | https://msd.nl/boxmeer/ |
| 监管批准 | Sequivity RNA颗粒平台已获美国农业部（USDA）批准，用于美国多项生猪相关应用 | https://pmc.ncbi.nlm.nih.gov/articles/PMC8528862/, https://www.merck-animal-health-usa.com/newsroom/merck-animal-health-introduces-sequivity-with-microsol-diluvac-forte-adjuvant-prescription-vaccine-for-use-in-gilts-and-sows/, https://www.msd-animal-health.com/about-us/our-story/ |

独立来源: brabantbusinessregion.com, investinholland.com, merck-animal-health-usa.com, msd.nl, pmc.ncbi.nlm.nih.gov

## 技术

- [兽医生物技术与 mRNA 兽药](https://cn.bioecon.ru/technology/veterinary-biotech-mrna-drugs/)